The rise of healthy aging: a new frontier in wellness
While science and knowledge drive many trends shaping the world, these shifts are followed by social, cultural and economic changes that, in turn, affect human societies. Whether this influence begins in isolated communities or not, it ultimately leads us to the globally interconnected world we live in today, compelling us to adapt, transform and integrate with these phenomena.
In recent years, the wellness industry has seen the emergence of new terms, concepts and vast untapped potential. One such concept is healthy aging, which is reshaping societal and individual consciousness.
It is also transforming this demographic segment into an attractive economic market — steering capitalism toward developing comprehensive product systems for it, while enabling older adults to remain active and influential in various areas of life.
This shift can impact society and national economies by enabling older people to stay healthy, productive and active, reducing the economic burden associated with healthcare, caregiving and welfare.
According to UN projections, the number of people aged 65 and older worldwide will double — from 761 million in 2021 to 1.6 billion by 2050. The population aged 80 and above is expected to grow even faster.
As time passes and life expectancy increases, and as rapid technological advances continue, the need for effective solutions to support healthier aging is becoming more urgent among these growing population segments.
This trend does not originate from top-down societal or governmental vision and planning. Rather, it stems from a personal and individual perspective — growing awareness among people who increasingly prioritize their well-being and longevity. This awareness has developed over the years due to multiple factors, including technological and societal progress, the effects of globalization and the impact of pandemics.
This article explores the evolving landscape of healthy aging and highlights the key factors that contribute to a fulfilling and vibrant later life. Healthy aging refers to the process of maintaining and enhancing functional capacity — relative to one's age — that supports well-being in older age. It goes beyond the mere absence of disease and includes the promotion of physical, mental and social health.
The core components of healthy aging include physical health, such as maintaining a balanced diet, regular exercise and managing chronic diseases; mental health, which involves supporting cognitive function, managing stress and promoting emotional well-being; and social connections, through meaningful relationships and active participation in community life to strengthen social support.
It also includes finding purpose and engagement, whether through work, volunteering or hobbies that bring a sense of fulfillment; and lastly, access to care — ensuring that older adults benefit from healthcare, social services and supportive environments.
Overall, healthy aging promotes a holistic approach to improving quality of life as people grow older.
One of the most important drivers of this trend is the shift in perspective — from merely preventing disease to enhancing effectiveness and life satisfaction. The concept of healthy aging now goes beyond avoiding age-related illnesses; it embraces a holistic approach that prioritizes both physical and mental health, fosters a sense of purpose and encourages active engagement with life. This shift reflects a growing recognition that a long life is only truly valuable when it is also healthy and fulfilling.
Specialized studies also indicate that social relationships and emotional engagement are key contributors to this growing trend. A recent study by the McKinsey Health Institute, which surveyed more than 21,000 people aged 55 and older across 21 countries, revealed a common thread: Purpose, social connection and independence are the most important factors for a positive aging experience.
The study found that people who maintain a sense of purpose, manage stress effectively and nurture meaningful relationships tend to report higher levels of overall well-being.
Mental and spiritual health also play a significant role in this trend. While physical health tends to decline with age, the study revealed that mental and spiritual well-being often remain strong. In fact, among those aged 65 and older, spiritual health emerged as the most positive dimension of overall well-being. This suggests that inner peace, personal growth and a sense of connection to something greater than oneself can deeply enrich life in later years.
The survey further highlighted the impact of economic status and community involvement on well-being. Interestingly, people in low- and middle-income economies generally reported better overall health than those in high-income countries. However, among people in high-income economies, those actively engaged in work, volunteering or community activities reported higher levels of well-being — highlighting the importance of purpose and social contribution in healthy aging.
This suggests that meaningful community engagement can significantly enhance the aging experience, regardless of economic status. The survey also found that volunteering, in particular, had a notably positive impact on future health, highlighting the importance of contributing to society and maintaining a sense of purpose — even after retirement.
Founded in 2018 and officially inaugurated in 2022, the Saudi Hevolution Foundation is the world's largest organization dedicated to healthy aging. Operating under the direct supervision of Crown Prince Mohammed bin Salman, the foundation has an annual budget of $1 billion to support research and develop treatments aimed at extending healthy lifespans.
It funds research projects lasting two to five years, with up to $1 million in support per project, and invests in biotechnology with contributions of up to $20 million. So far, the foundation has backed 25 projects within Saudi Arabia and 225 international initiatives in the same field.
To create a world where everyone can age healthier and happier, a collaborative effort is required — from regulators, communities, and investors — to meet the needs of older adults and help them lead fulfilling lives. This includes promoting a positive view of aging, not as a passive end-of-life stage, but as a meaningful chapter of continued growth, engagement and purpose. It is essential to challenge and reverse the outdated stereotype of aging as a time of decline.
Instead, aging should be seen as a phase rich with opportunities to learn, contribute and pass on knowledge to younger generations — building a more developed and forward-looking society that does not repeat the same patterns with each generation.
Complementary medicine also plays a supportive role in healthy aging, contributing to prevention and improved quality of life through safe, natural treatments. This aligns with Saudi Arabia's broader vision of becoming a leading destination for global health tourism.
Ultimately, by adopting a comprehensive and inclusive approach to healthy aging, we can build a world where everyone has the chance to live a long, healthy and fulfilling life.
• Saad Majdy Baslom has more than 10 years' experience in health tourism, wellness services, management, regulation and policy as a technical affairs director in complementary medicine. He holds a leadership and management certificate from the Massachusetts Institute of Technology, a doctorate in traditional Chinese medicine, and master's degrees in Chinese herbology and acupuncture.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Arabiya
a day ago
- Al Arabiya
The new generation of blockbuster weight-loss drugs, explained
A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few years, though they do have some drawbacks. After France on Friday became the latest country to allow all doctors—rather than just specialists—to prescribe these drugs, here are some key questions about them. How do they work? The most well-known of this new wave of drugs are Danish pharma firm Novo Nordisk's Ozempic and Wegovy, as well as US company Eli Lilly's Mounjaro. These drugs enhance the action of a hormone in the pancreas called 'glucagon-like peptide 1,' or GLP-1, the name given to this family of medications. The hormone affects the secretion of insulin, so it was first targeted to develop drugs to combat diabetes. But it turned out that GLP-1 drugs also suppress people's appetite by making them feel fuller. A revolution? Obesity experts now agree that these drugs are a historic breakthrough in the history of people trying to lose weight. Previously, surgery was the main option for obesity when diet and exercise did not work. This is no small feat. Obesity affects 900 million people worldwide, in what is considered a major crisis. The new drugs 'cover a major unmet need: obesity was one of the only chronic diseases for which there were few medications,' French endocrinologist Emmanuel Disse told AFP. During clinical trials, the drugs have been found to reduce people's weight by an average of 15 to 20 percent. Limitations? However, these drugs do have some limitations, including side effects. The semaglutide drug used in Ozempic has been approved for diabetes since 2017, so there is now nearly a decade of research on its use. A large study using health data from hundreds of thousands of US veterans published in January found that GLP-1s are not linked to a higher risk of heart problems or suicidal thoughts, as had previously been suggested. However, there are rare cases of serious side effects, such as damage to the pancreas, it said. More commonly, they can also cause nausea, vomiting, migraines and disturb sleep, which can turn some patients off the drugs. They also do not work for everyone—some people taking the drugs do not lose weight. And the effect only lasts when people are taking the drug, meaning that they potentially need lifelong treatment. They are also expensive, sometimes costing over $1,000 a month in the United States to 300 euros ($340) in France. The drugs are also only available in injectable forms—though pharma firms are developing daily pills that have shown promise in early trials. Who should use them? National health agencies have emphasized that these drugs should only be prescribed to overweight or obese people for whom things like exercise and diet have failed. However, there is plenty of evidence that some people who are not overweight use the drugs simply to lose a few extra kilos. France's ANSM medications authority said that these drugs should 'not be used for weight loss for aesthetic purposes,' warning that inappropriate use could expose people to 'adverse effects that are sometimes serious.' What next? Steven O'Rahilly, head of Cambridge University's Institute of Metabolic Sciences, told AFP he was confident there will be 'a pretty rapid evolution of drugs that are more effective, with fewer side effects, cheaper and more convenient.' 'It may be more of a challenge to combine all those four advances in a single medicine,' he added. With billions of dollars at stake, pharma firms are racing to be the first to market with a new treatment. Novo Nordisk's experimental drug amycretin could be even more effective than existing GLP-1s, according to early trial results published in The Lancet on Saturday. There has also been a growing field of research revealing the potential benefits of GLP-1 drugs beyond obesity. They have been linked to improvements for a range of maladies, including dementia and addiction. It is still unclear if these are a direct effect of the drugs or are linked to improvements with obesity or diabetes.
Arab News
a day ago
- Arab News
KSrelief distributes shelter aid in Somalia's Togdheer region
TOGDHEER: The King Salman Humanitarian Aid and Relief Center recently distributed 1,030 pieces of clothing, 475 shelter bags, and 20 tents to several camps in the Togdheer region of Somalia, benefiting 1,525 families and 9,150 individuals. The assistance comes as part of a 2025 initiative to distribute shelter aid to displaced persons in the African country. Earlier, three relief trucks provided by the Saudi aid agency arrived on Wednesday in the town of Sarmada in Syria's Idlib governorate, carrying 20 tonnes of medical aid. The assistance will be distributed in cooperation with the UN World Health Organization to 45 healthcare facilities in northwestern Syria, based on field-identified needs. The aid supports frontline medical teams in underserved areas, benefiting about 150,000 people. Elsewhere, the agency distributed 3,000 cartons of dates to families in need in the Shabwa governorate of Yemen, benefiting 18,000 individuals.
Arab News
a day ago
- Arab News
Pakistan reports new polio case in northwest, raising 2025 tally to 12
KARACHI: Pakistan's polio eradication program on Friday said a new wild poliovirus case had been detected in the country's northwestern Khyber Pakhtunkhwa province, bringing the total tally of 2025 cases to 12. Polio is a paralyzing disease with no cure, making prevention through vaccination critical. Multiple doses of the oral polio vaccine, along with the completion of the routine immunization schedule for all children, are essential to build strong immunity against the virus. The country conducted three nationwide vaccination campaigns in February, April and May, aiming to immunize around 45 million children across Pakistan with the support of over 400,000 frontline workers including 225,000 women vaccinators. 'The Regional Reference Laboratory for Polio Eradication at the National Institute of Health, Islamabad, has confirmed a new case of wild poliovirus in District Bannu, South Khyber Pakhtunkhwa,' the body said in a statement. 'The 33-month-old male child from Union Council Shamsikhel, District Bannu is the sixth case of polio reported from Khyber Pakhtunkhwa this year.' Pakistan has reported 12 polio cases so far this year, including six from Khyber Pakhtunkhwa, four from the southern Sindh province and one each from the populous Punjab province and the northern Gilgit-Baltistan region. Pakistan, one of the last two countries where polio remains endemic along with Afghanistan, has made significant progress in curbing the virus, with annual cases dropping from around 20,000 in the early 1990s to just eight in 2018. However, the country reported an alarmingly high number of 74 cases in 2024, after six in 2023 and only one in 2021. Health Minister Mustafa Kamal on Thursday claimed that Pakistan has recorded a 99 percent decline in polio cases, as he urged global vaccine organization Gavi to invest more in efforts to 'train and retain' vaccinators. Pakistan launched its polio eradication program in 1994, but its efforts have repeatedly been hindered by widespread vaccine misinformation and resistance from hard-line religious groups who claim immunization campaigns are a Western conspiracy to sterilize Muslim children or a front for espionage. Militant groups have also targeted polio workers and police officials providing them security, often with deadly attacks that have hampered vaccination drives, particularly in the country's remote and conflict-prone regions.
